Increased Serum Concentration of Angiogenic Factors in Malignant Melanoma Patients Correlates With Tumor Progression and Survival
Top Cited Papers
- 15 January 2001
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 19 (2) , 577-583
- https://doi.org/10.1200/jco.2001.19.2.577
Abstract
PURPOSE: To determine the predictive value of the angiogenic serum factors angiogenin, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8) for...Keywords
This publication has 25 references indexed in Scilit:
- Circulating vascular endothelial growth factor (VEGF) is not a prognostic indicator in malignant melanomaCancer Letters, 1998
- Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancerAnnals of Oncology, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- PROGNOSTIC SIGNIFICANCE OF MICROVESSEL COUNT IN LOW STAGE RENAL CELL CARCINOMAInternational Journal of Urology, 1995
- Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumour loadMelanoma Research, 1995
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- The observation of angiogenin and basic fibroblast growth factor gene expression in human colonic adenocarcinomas, gastric adenocarcinomas, and hepatocellular carcinomasThe Journal of Pathology, 1994
- Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast CarcinomaNew England Journal of Medicine, 1991
- International Trends in Cutaneous MelanomaAnnals of the New York Academy of Sciences, 1990